News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CEA-Leti And Akrivis Technologies To Develop Nanomedicine Platform For High Payload Targeted Drug Delivery


6/19/2014 9:17:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GRENOBLE, France--(BUSINESS WIRE)--CEA-Leti and Akrivis Technologies, LLC announced their collaboration to develop an extremely adaptable, efficient and highly targeted drug delivery platform for chemotherapy and other treatments that require a high concentration of powerful drugs to be delivered precisely to targeted cells.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES